- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04212156
Thyromental Height Test (TMHT) as a Predictor of Difficult Airway in Obese Patients
May 14, 2021 updated by: Abeer Ahmed, MD, Cairo University
Validity of Thyromental Height Test (TMHT) as an Objective Predictor of Difficult Airway in Obese Patients: a Prospective Observational Cohort Study
Difficult airway management is a major concern for anesthetists and contributes to perioperative morbidity and mortality.
The incidence of difficult intubation in the obese population with a BMI of greater than 30 has been reported to be 15.8%.
Thyromental height test (TMHT) is a new bedside test for difficult airway, it is a measure of the height between the anterior borders of the mentum and thyroid cartilage.
TMHT can act as a surrogate for amount of mandibular protrusion; dimensions of submandibular space; and anterior position of the larynx.
It appears promising as a single anatomical measure to predict the risk of difficult laryngoscopy.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
105
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Cairo
-
Maadi, Cairo, Egypt, 11562
- Abeer Ahmed
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 60 years (ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Patients of both sex, aged between 18-60 years old, ASA physical status II& III with BMI > 30 Kg/m2 who will undergo elective surgical procedures under general anesthesia using endotracheal intubation using conventional laryngoscopy
Description
Inclusion Criteria:
- Patients aged between 18-60 years old, ASA physical status II& III with BMI > 30 Kg/m2 who will undergo elective surgical procedures under general anesthesia using endotracheal intubation with conventional laryngoscopy
Exclusion Criteria:
- Patients with neuromuscular disorders, craniofacial abnormalities, abnormal dentition, uncooperative, who need awake intubation and patients who undergoing emergency operations will be excluded
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
TMH test
Patient will be asked to lay supine while the head and neck maintained in a neutral position using a pillow under the head.
By using digital depth gauge, the TMH will be measured from the anterior border of the thyroid cartilage directly on the thyroid notch till the anterior border of the mentum
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
TMHT
Time Frame: before induction of general anesthesia
|
Validity of TMHT for prediction of difficult airway in obese patient undergoing general anesthesia
|
before induction of general anesthesia
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
January 20, 2020
Primary Completion (ACTUAL)
January 20, 2020
Study Completion (ACTUAL)
January 20, 2021
Study Registration Dates
First Submitted
December 23, 2019
First Submitted That Met QC Criteria
December 24, 2019
First Posted (ACTUAL)
December 26, 2019
Study Record Updates
Last Update Posted (ACTUAL)
May 17, 2021
Last Update Submitted That Met QC Criteria
May 14, 2021
Last Verified
May 1, 2021
More Information
Terms related to this study
Other Study ID Numbers
- Ms-266-2019
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Difficult Airway Intubation
-
Michael MaRecruitingDifficult Intubation | Difficult Airway IntubationIreland
-
Lazarski UniversityCompletedIntubation; Difficult or Failed | Difficult Airway | Intubation;DifficultPoland
-
Derince Training and Research HospitalCompletedDifficult Intubation | Difficult AirwayTurkey
-
J. Matthias WalzTerminatedSurgery | Difficult Intubation | Anesthesia | Difficult Airway Intubation | Speech DysfunctionUnited States
-
Kırıkkale UniversityCompletedDifficult Airway IntubationTurkey
-
University College Hospital GalwayTerminatedDifficult Intubation | Airway | Airway DeviceIreland
-
Campus Bio-Medico UniversityCompletedDifficult Airway IntubationItaly
-
Rigshospitalet, DenmarkCompletedDifficult Airway | Tracheal IntubationDenmark
-
Wake Forest University Health SciencesTerminatedDifficult Intubation | Awake Endotracheal Intubation | Airway AnesthesiaUnited States
-
University Hospital, CaenCompletedAirway Complication of Anesthesia | Intubation;Difficult | Awake IntubationFrance